We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,176.00 +8.50 (+0.16%) Dow Futures
38,292.00 +54.00 (+0.14%) Nasdaq Futures
18,215.00 +35.75 (+0.20%) Russell 2000 Futures
2,028.80 +9.00 (+0.45%) Crude Oil
85.43 -0.23 (-0.27%) Gold
2,373.20 -0.90 (-0.04%)
Insulet Corporation (PODD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 179.65 |
| Open | 177.63 |
| Bid | 175.15 x 100 |
| Ask | 175.34 x 100 |
| Day's Range | 174.12 - 178.38 |
| 52 Week Range | 125.82 - 335.91 |
| Volume | |
| Avg. Volume | 861,940 |
| Market Cap | 12.269B |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | 59.60 |
| EPS (TTM) | 2.94 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 236.83 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PODD
Related Research
- Insulet CorporationAnalyst Report: Insulet CorporationInsulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.RatingFair ValueEconomic Moat2 months agoMorningstar
ZacksWill Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ZacksInsulet (PODD) Stock Moves -0.34%: What You Should Know
Insulet (PODD) concluded the recent trading session at $177.41, signifying a -0.34% move from its prior day's close.
ZacksNeogen (NEOG) Q3 Earnings Miss Estimates, Gross Margin Expands
Neogen's (NEOG) third-quarter fiscal 2024 results reflect solid core revenue growth in both segments.
Business WireInsulet to Announce First Quarter 2024 Financial Results on May 9, 2024
ACTON, Mass., April 03, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2024 on May 9, 2024 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).
ZacksHere's Why Insulet (PODD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks5 Medical Product Stocks to Buy Amid Industry Challenges
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.
ZacksWall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?
The consensus price target hints at a 38.9% upside potential for Insulet (PODD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Simply Wall St.Investors Will Want Insulet's (NASDAQ:PODD) Growth In ROCE To Persist
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
ZacksThe Zacks Analyst Blog Highlights Twilio, Zscaler, NextEra Energy, and American Water Works
Twilio, Zscaler, NextEra Energy, and American Water Works are part of the Zacks top Analyst Blog.
Zacks5 Stocks to Buy on the Dip to Gain From the Wall Street Rally
We have narrowed our search to five large-cap stocks with attractive valuations. These are TWLO, ZS, NEE, AWK and PODD.
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| DXCM DexCom, Inc. | |||
| TNDM Tandem Diabetes Care, Inc. | |||
| PEN Penumbra, Inc. | |||
| MASI Masimo Corporation | |||
| SWAV Shockwave Medical, Inc. |
Similar to PODD
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| TNDM Tandem Diabetes Care, Inc. | |||
| DXCM DexCom, Inc. | |||
| NARI Inari Medical, Inc. | |||
| INSP Inspire Medical Systems, Inc. | |||
| ALGN Align Technology, Inc. |
Analyst Price Targets (18)
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/26/2024 | |
| Maintains | Piper Sandler: Overweight to Overweight | 2/23/2024 | |
| Maintains | JP Morgan: Overweight to Overweight | 2/23/2024 | |
| Maintains | Stifel: Hold to Hold | 2/5/2024 | |
| Upgrade | Baird: Neutral to Outperform | 12/21/2023 | |
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 12/4/2023 |
Company Profile
100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 3,000
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
